Skip to main content
Glama

Materials

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description discloses internal cascading ('Each call cascades through several lookup endpoints internally'), graceful degradation ('if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return'), and ambiguity handling ('returns figi_candidates to pick from'). Annotations already mark the tool read-only and safe, so the description adds substantial behavioral context beyond what annotations provide.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but densely packed with useful information. It is structured with SUPPORTED TYPES and front-loaded with examples. While it could be shorter, each section contributes to correct usage; it's comprehensive without being repetitive.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description thoroughly covers return behavior: identifier sources, unresolved identifiers handled under `unresolved`, and ambiguous matches producing `figi_candidates`. It also notes the tool replaces multiple manual lookups, setting expectations. This is complete for the tool's complexity.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The input schema covers both parameters at 100%, but the description adds essential meaning: examples (ticker, CIK, ISIN, brand name), constraints (e.g., never pass the full noun phrase for bonds), and type-specific behavior. This elevates the guidance well above the schema descriptions alone.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description explicitly states the purpose: 'resolve a user-spoken NAME to the canonical/official identifiers other tools require as input.' It provides concrete example queries and lists supported types, making the tool's function unmistakable and distinguishing it from other tools that consume identifiers.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives clear guidance with 'Use FIRST whenever you have a name but need an ID.' It includes specific parameter instructions like 'Pass the ENTITY NAME ONLY' and warns against including trailing security-class words. However, it doesn't explicitly name alternative tools or conditions when not to use it, so it's not a 5.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Materials toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation3/5

While many tools have detailed descriptions that help differentiate them, there is significant overlap among query tools like ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, and deep_research. The prediction market tools also cluster together, making it challenging for an agent to quickly pick the right one without careful reading.

Naming Consistency4/5

Most tools follow a descriptive snake_case convention (e.g., ask_pipeworx, entity_profile, compare_entities). Minor deviations exist, such as 'ai_visibility_check' and 'deep_research', but overall the naming pattern is predictable and clear.

Tool Count3/5

With 33 tools, the server is larger than typical single-domain servers. While it supports a broad data platform, this count feels somewhat bloated and could benefit from consolidation, especially among overlapping query tools.

Completeness1/5

The server is named 'Materials' but contains only two materials-specific tools (materials_search, materials_stability). The remaining 31 tools cover unrelated domains (finance, economics, prediction markets, etc.), leaving the stated domain severely incomplete.

Resources